These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Psychiatric disorders with use of simvastatin]. Duits N; Bos FM Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1312-5. PubMed ID: 8345888 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of new drugs for lowering plasma cholesterol concentrations. Illingworth DR Drugs; 1991 Feb; 41(2):151-60. PubMed ID: 1709846 [No Abstract] [Full Text] [Related]
5. An overview: long-term tolerability of lovastatin and simvastatin. Bilheimer DW Zhonghua Yi Xue Za Zhi (Taipei); 1992 Feb; 49(2):138-9. PubMed ID: 1315197 [No Abstract] [Full Text] [Related]
6. Statin therapy and CHD. Tobert JA Lancet; 1996 Jan; 347(8994):128. PubMed ID: 8538331 [No Abstract] [Full Text] [Related]
7. [Simvastatin in the treatment of hypercholesterolemia]. Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606 [TBL] [Abstract][Full Text] [Related]
9. Proteinuria as complication of simvastatin treatment. Deslypere JP; Delanghe J; Vermeulen A Lancet; 1990 Dec; 336(8728):1453. PubMed ID: 1978916 [No Abstract] [Full Text] [Related]
10. Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia. Barth JD; Kruisbrink OA; Van Dijk AL BMJ; 1990 Sep; 301(6753):669. PubMed ID: 2224231 [No Abstract] [Full Text] [Related]
11. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
12. Reductase inhibitor therapy of hypercholesterolemia. Kreisberg RA Trans Am Clin Climatol Assoc; 1991; 102():153-63; discussion 163-5. PubMed ID: 2130558 [No Abstract] [Full Text] [Related]
13. Simvastatin. Yeatman E Aust Nurses J; 1991 Jul; 21(1):29-30. PubMed ID: 1929970 [No Abstract] [Full Text] [Related]
14. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations. Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973 [No Abstract] [Full Text] [Related]
15. Lipid control with low-dosage simvastatin in patients with moderate hypercholesterolaemia. An Italian multicentre double-blind placebo-controlled study. Capurso A; Resta F; Bertolini S; Masturzo P; Feruglio FS; Cattin L; Da Col PG; Descovich GC; Gaddi A; Urbinati GC Eur Heart J; 1992 Jul; 13 Suppl B():11-6. PubMed ID: 1644094 [No Abstract] [Full Text] [Related]
16. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias. Aronson JK; Ng LL Q J Med; 1990 Feb; 74(274):111-5. PubMed ID: 2111916 [No Abstract] [Full Text] [Related]
18. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients. Arnadottir M; Eriksson LO; Germershausen JI; Thysell H Nephron; 1994; 68(1):57-62. PubMed ID: 7991041 [TBL] [Abstract][Full Text] [Related]
19. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin. Maher VM; Thompson GR Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917 [TBL] [Abstract][Full Text] [Related]
20. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin]. Brocard JJ; Keller U; Oberhänsli A; Riesen WF Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]